SATURDAY, OCTOBER 13, 2018
Impulse Control Behaviours and Creativity in Parkinson's

Lectures are held at Parkinson Voice Project and will be streamed live on our home page and Facebook page at 10:30am (CT).
A video of this lecture will be posted online by October 19, 2018.

Presenter


Mark Kelly, MD

[ SEE BIO BELOW ]

Lecture Description
Impulse control behaviours are a common side effect of dopaminergic medication in Parkinson’s, characterized by their reward-based, repetitive natures and include pathological gambling, hypersexuality, compulsive shopping, binge-eating, and others. These impulsive behaviours can cause significant psychological, social, and even financial harm to both patients themselves and those close to them but have also been linked to productive characteristics such as creativity. While a lot is known about the prevalence of these behaviours, there has been little objective assessment of their severity, their impact on quality of life, and the clinical significance of milder, ‘subsyndromal’ behaviours.   This lecture explores what we know so far about impulse control behaviours in Parkinson’s and takes a look at work being carried out by the Oxford Discovery Project to better understand these effects. This knowledge helps not only in better directing available therapies, but also improves our understanding of some of the underlying pathological processes involved in Parkinson’s.

Learner Outcomes
• Describe three examples of impulse control behaviours that can occur in Parkinson’s.
• Describe the medications that can cause impulse control behaviours.
• Describe how creativity can be a positive outcome of these same medications.

Register for In-Person
10:30am Lecture
Registration opens September 7th
ABOUT THE PRESENTER

Mark Kelly, MD

Financial Relationship: Receives an honorarium for his lecture at Parkinson Voice Project.
Nonfinancial Relationship: None.

Dr. Mark Kelly is a researcher at the Oxford Parkinson’s Disease Centre, based at Oxford University in the United Kingdom. He qualified at Trinity College Dublin and is currently training in general medicine with a keen interest in neurology and Parkinson’s disease. His research with the Oxford Discovery Project, led by Professor Michele Hu, focuses on the side effects of dopaminergic therapies, including impulse control behaviours, exploring the predictors of the effects, and clinically characterizing the impact they have on patients.